Topological patterns of damage and compensation in chronic neuroinflammation

B05

Although research has made significant progress, there are still mechanistic factors that markedly influence disease progression and compensation reserve, making an accurate prognosis of sub-group and individual disease courses in MS extremely challenging. We aim at elaborating the framework for the automatic stratification of disease courses and therapeutic responses. Using advanced magnetic resonance imaging (MRI) together with brain networks phenotyping and immune response analyses, we aim to early recognize patients at high risk for disease progression (i.e. evolving functional impairment) or with insufficient therapeutic responses to immunomodulation:

    1. Can the acute individual network response help to predict future relapses and long-term disease trajectories?
    2. What is the difference in chronic network responses between patients with continuous functional worsening compared to clinically stable patients?
    3. How do the predictive differences of grey matter (GM) and white matter (WM) lesion localization impact on network dynamics and disease progression?
    4. What is the role of cortical lesions and their corresponding dynamics (enlarging, smoldering lesions) for WM and GM network reorganization and evolving functional impairment?
    5. Can peripheral immunological markers be linked to data from MRI network analysis to improve the understanding of the pathomechanisms underlying network reorganization in MS?

 

 

 

 

 

 

 

 

 

 

 

Principal Investigators:

Prof. Dr. med. Sergiu Groppa
Klinik für Neurologie
Mainz
segroppa@uni-mainz.de

Prof. Dr.-Ing. Muthuraman Muthuraman
Klinik für Neurologie
Mainz
mmuthura@uni-mainz.de

Univ.-Prof. Dr. med. Dr. rer. nat. Dr. h.c. Sven G. Meuth
Klinik für Neurologie
Düsseldorf
sven.meuth@med.uni-duesseldorf.de

News

Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more